Pepto-Bismol and Mounjaro: can you take them together?

Mounjaro (tirzepatide) slows gastric emptying significantly, which affects how quickly all oral medicines and some supplements are absorbed.
Bismuth subsalicylate (the active ingredient in Pepto-Bismol) can itself cause constipation, a side effect that Mounjaro already raises your risk of.
Pepto-Bismol contains salicylate, which is chemically related to aspirin; people with certain conditions, or those on anticoagulants, should check before using it regardless of Mounjaro.
Nausea and stomach discomfort during the early weeks of Mounjaro treatment usually settle on their own; your prescriber may have better-targeted suggestions than an antacid product.

Your stomach is unsettled, there's a bottle of Pepto-Bismol in the bathroom cabinet, and you're on Mounjaro. Whether that combination is safe is a completely fair question — and the short answer is that there is no documented pharmacokinetic interaction between bismuth subsalicylate (the active ingredient in Pepto-Bismol) and tirzepatide, but there are reasons to think carefully before reaching for it. These are prescription-only medicines requiring clinical assessment, and any decision about adding over-the-counter products should involve your prescriber or pharmacist. The sections below give you the facts so that conversation can start from the right place.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The practical detail: Pepto-Bismol, tirzepatide, and your digestive system

You've taken your pen this week and now your stomach's complaining

This is the situation a lot of people find themselves in, especially in the first few weeks or after a dose step-up. Mounjaro works partly by slowing the rate at which food leaves your stomach — a mechanism that reduces appetite but can also trigger nausea, indigestion, or loose stools, particularly if you've eaten a large or fatty meal. The discomfort is real, and it makes sense that you'd scan the medicine cabinet for relief.

Pepto-Bismol's main job is to coat the stomach lining, reduce irritation, and slow intestinal movement. For ordinary stomach upsets it works well. On Mounjaro, though, the picture is slightly more complicated, and if you want the full detail on how the two interact, our Pepto-Bismol and Mounjaro page covers it thoroughly. Tirzepatide is already slowing gastric emptying; adding bismuth subsalicylate slows transit further. If constipation is part of what's bothering you, Pepto-Bismol could make it worse rather than better. It's worth checking the label to confirm which symptom the product is actually targeting before you open it, a one-minute habit that catches a lot of avoidable mistakes.

There's also the absorption question. Because Mounjaro delays how quickly the stomach empties, oral medicines taken alongside it can behave differently, their absorption may be slower or more variable. This doesn't mean Pepto-Bismol is harmful, but it does mean the timing of other oral medicines you take matters. The NHS tirzepatide medicines page notes this interaction potential explicitly, and it's the starting point for any query about combining tirzepatide with other oral products.

The gastric-emptying effect and why it matters for anything you swallow

Mounjaro's dual GIP and GLP-1 receptor agonism makes it distinctive among weight-loss medicines; that same mechanism is why its effect on the gut is stronger than some people expect. Gastric emptying slows noticeably, especially at higher doses. For oral contraceptives, this is significant enough that the prescribing guidance for tirzepatide recommends adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, precisely because pill absorption can be reduced.

Pepto-Bismol is not in the same category of clinical concern, but the principle is the same: the stomach is working at a different pace than usual, and that changes the environment for everything you put in it. If you're using Pepto-Bismol to manage nausea specifically, it's worth knowing that antiemetics work through different pathways and your prescriber may consider one of those more appropriate for GLP-1-related nausea. Staying well-hydrated and eating smaller, lower-fat meals is often the first-line advice for GI symptoms on Mounjaro, simple, but genuinely effective for many people.

You can read more about how tirzepatide works as a molecule on the tirzepatide overview page, which covers the dual-receptor mechanism in fuller detail. Part of what makes tirzepatide's mechanism distinctive is its molecular identity, and if you've ever wondered whether Mounjaro is classed as a peptide, we explain exactly how it's categorised and why that matters.

When to stop and call someone rather than reaching for any over-the-counter product

Most GI discomfort on Mounjaro is mild and short-lived. But some symptoms need medical attention rather than a cabinet remedy. Severe stomach pain (especially pain that radiates through to your back, with or without vomiting) requires urgent assessment because it can be a sign of pancreatitis, a known though infrequent side effect of GLP-1 medicines. The MHRA issued a specific safety communication on this in early 2026. Signs of significant dehydration from persistent vomiting or diarrhoea also warrant a call to your GP or 111, not a dose of Pepto-Bismol.

If your stomach symptoms are severe, repeated, or getting worse rather than better, the right move is to contact your prescriber. At nume, aftercare is available seven days a week, so if something doesn't feel right, that conversation doesn't have to wait until Monday morning. You can reach the team via the contact page.

For a broader look at what Mounjaro treatment involves (eligibility, what happens at each stage, and what the evidence shows) the Mounjaro treatment page covers all of it. And if you're curious about where Mounjaro sits in the wider category of treatments, the FAQs page addresses common queries about how the service works, including questions about the peptide name behind Mounjaro for those who like to understand the science. Pricing context, for those weighing up private options, is set out honestly on the Mounjaro prices page.

If you're not yet on treatment and would like a prescriber to assess your suitability, the team at nume reviews consultations the same day a real clinician, not a screening tool, reads your answers. Speak to our prescribers to get started.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions